Australian Government - Department of Health

Medical Services Advisory Committee (MSAC)

1192-Percutaneous Reconstruction of an Insufficient Mitral Valve through Tissue Approximation using Transvenous/ Transeptal Techniques

The documents on this page may not be accessible, should you require assistance accessing the information please contact the MSAC Secretariat.

Resubmissions:
A subsequent application has been submitted, please refer to the resubmitted application 1192.1
Assessment No1192
Application NamePercutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques
Assessment TypeSubmission Based Assessment
Description of Medical ServicePercutaneous reconstruction of an insufficient mitral valve through tissue approximation using transvenous/transeptal techniques is performed while the heart is beating, which better allows the identification of the origin of mitral regurgitation (MR).
Description of Medical ConditionMR occurs when the leaflets (or flaps) of the heart’s mitral value do not close properly and leak. The mitral valve is a one-way valve that separates the left atrium (a chamber in the heart which collects blood from the lungs) from the left ventricle (a chamber in the heart which pumps blood to the rest of the body). During pumping, the leak in the mitral valve causes blood to flow backwards (MR) into the left atrium, thereby decreasing blood flow to the body. To maintain blood flow to the body and compensate for the MR, the left ventricle must pump harder. Back flow due to MR places an extra burden on the left ventricle and lungs. Eventually, this burden can cause other problems such as: stroke, sudden death, irregular heartbeat, increasing damage to the heart muscle (progressive myocardial injury); inability to maintain adequate circulation of blood (congestive heart failure).
Pre Assessment Meeting4 July 2011
Stage 2 – Suitability for Assessment-
Lodgement of Proposed DAP10 November 2011
Stage 3 – 1st PASC (Draft DAP considered)1 – 2 December 2012
Stage 3 – Release for Public Comment (Consultation DAP)Date of released for comment 27 January 2012
PDF version Consultation Decision Analytic Protocol (DAP) (PDF 451 KB)
Word version Consultation Decision Analytic Protocol (DAP) (Word 1147 KB)
Date closed for comments 10 March 2012
Stage 3 – 2nd PASC (Final DAP)12 – 13 April 2012
PDF version Final Decision Analytic Protocol (DAP) (PDF 2090 KB)
Word version Final Decision Analytic Protocol (DAP) (Word 2100 KB)
Stage 4 – Submission of Collated EvidenceReceived 14 June 2012
The Submission has been withheld at the request of the Applicant
Stage 5 – ESC Evaluation11 – 12 October 2012
Stage 6 – MSAC Appraisal29 – 30 November 2012
Stage 6 – MSAC AdvicePDF version Public Summary Document (PDF 836 KB)
Word version Public Summary Document (Word 248 KB)
Stage 7 – Noting by Minister-
Stage 8 – Implementation-

Page currency, Latest update: 06 April, 2016